(WORX) Scworx - Ratings and Ratios

SCWorx Corp (NASDAQ:WORX) is a healthcare technology company that provides data content and services to repair, normalize, and ensure interoperability of information for healthcare providers in the US. The companys solutions aim to improve healthcare processes and information flow within hospitals and other healthcare facilities. Its software modules offer a range of functions, including data management, contract management, and big data analytics, which are sold to hospitals and health systems through a direct sales force and partnerships.

With a focus on healthcare IT, SCWorx Corps products and services are designed to address the complexities of healthcare data management, enabling providers to make informed decisions and improve patient care. The companys expertise in data integration and warehousing, as well as its ability to automate and streamline healthcare processes, positions it as a valuable partner for healthcare organizations seeking to optimize their operations.

From a technical analysis perspective, WORXs stock price has been trending downward, with its 20-day, 50-day, and 200-day simple moving averages (SMA) indicating a bearish trend. The stocks last price is $0.40, with an average true range (ATR) of $0.08, representing a volatility of 19.66%. Given the current market capitalization of $1.37M USD and the absence of a price-to-earnings (P/E) ratio, it is clear that the companys financial performance is a concern.

Using historical data and fundamental analysis, a forecast for WORXs stock price can be made. Considering the companys negative return on equity (RoE) of -81.51% and the lack of a P/E ratio, it is likely that the stock will continue to face downward pressure. However, if the company can demonstrate significant improvements in its financial performance and successfully execute its business strategy, there may be potential for a rebound. Based on the technical data, a potential support level is seen at the 52-week low of $0.40. A break below this level could lead to further declines, while a sustained bounce off this level could indicate a potential reversal. A forecast for the next 6-12 months could see the stock price potentially trading in a range between $0.30 and $0.60, with a possible bias towards the lower end of this range if the companys financial performance does not show significant improvement.